Navigate Trial features in Department of Veterans’ Affairs Newspaper 2020
The Department of Veterans’ Affairs (DVA) showed support of the Navigate trial by featuring an article in their 2020 winter edition of Vetaffairs. Vetaffairs is the DVA’s official newspaper for Australia’s veteran community. This online newspaper has a wide readership throughout Australia and we hope this article will reach men newly diagnosed with low-risk prostate cancer and who might be interested to participate.
Click image to read the full article in a new tab.
Read the full article here. Extract provided below:
The website, Navigate, is designed to help men make more informed decisions about their diagnosis by providing information about prostate cancer, treatment options, side effects, and ways to keep healthy after diagnosis.
The trial is coordinated by the Peter MacCallum Cancer Centre in Melbourne in conjunction with Swinburne University. But while it’s being led from Melbourne, it is open to men with a recent diagnosis from anywhere in Australia and is a collaboration between medical facilities from around Australia.
Consultant urologist Professor Declan Murphy said low-risk prostate cancer often grows very slowly or not at all, yet men faced with this diagnosis reported more difficulty making a treatment decision than any other cancer clinical group.
This was largely due to the variety of management options including Active Surveillance (close monitoring) versus active treatment like radiotherapy or surgery.
‘It can be somewhat challenging for men to consider which option is best for them when confronted with a cancer diagnosis,’ Professor Murphy said.
Published on 7 July 2020 by the Department of Veterans’ Affairs.
Read the full article here:
https://www.dva.gov.au/newsroom/vetaffairs/vetaffairs-vol-36-no2-winter-2020/online-guide-prostate-treatment-decisions
In Vetaffairs’ hard-copy version of their newsletter, a snapshot of Navigate’s appearance on this version can be seen below:
If you are reading this article before 31st April 2021 and have recently been diagnosed with early-stage, low-risk prostate cancer, please consider joining our research trial www.navigateprostate.com.au to help navigate your treatment options.
We’d love to hear from you!
[email protected] | (03) 8559 7453
Need questions answered now?
Call Cancer Council 13 11 20 Information and Support line from anywhere in Australia.
